Year archive

Moberg Pharma — 2026 filings

All 11 regulatory filings released by Moberg Pharma (MOB) in 2026, sourced directly from the official regulator.

11 Filings

2026 Period

2026 filings (11)

Filing	Released	Lang
Interim / Quarterly Report 2026 Interim / Quarterly Report Q1 2026	2026-05-12	Swedish
Interim / Quarterly Report 2026 Interim / Quarterly Report Q1 2026	2026-05-12	English
Moberg Pharma och Karo Healthcare expanderar samarbete för MOB-015/Terclara till Australien, Nya Zeeland, Sydkorea och Taiwan Regulatory Filings	2026-04-24	Swedish
Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to Australia, New Zealand, South Korea and Taiwan Regulatory Filings	2026-04-24	English
Notice of Annual General Meeting in Moberg Pharma AB (publ) AGM Information	2026-04-17	English
Kallelse till årsstämma i Moberg Pharma AB (publ) Proxy Solicitation & Information Statement	2026-04-17	Swedish
Annual Report (ESEF) 2025 Annual Report (ESEF) FY 2025	2026-04-17	Swedish
Additional terbinafine supplier approved Regulatory Filings	2026-03-13	English
Ytterligare en terbinafin-leverantör godkänd Regulatory Filings	2026-03-13	Swedish
Earnings Release 2025 Earnings Release Q4 2025	2026-02-17	Swedish
Audit Report / Information 2025 Audit Report / Information FY 2025	2026-02-17	English

Filings by year

2026 11 filings
2025 36 filings
2024 62 filings
2023 56 filings
2022 40 filings
2021 39 filings
2020 62 filings
2019 83 filings
2018 53 filings
2017 44 filings
2016 70 filings
2015 55 filings
2014 48 filings
2013 51 filings
2012 56 filings
2011 16 filings